PRESS RELEASE published on 02/24/2025 at 21:27, 11 months 12 days ago Sanofi: Disclosure of trading in own shares
BRIEF published on 02/22/2025 at 08:35, 11 months 14 days ago Sanofi-Teva: Duvakitug Promises for Inflammatory Bowel Diseases Ulcerative Colitis Crohn's Disease Duvakitug RELIEVE UCCD Sanofi-Teva
PRESS RELEASE published on 02/22/2025 at 08:30, 11 months 14 days ago Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease Sanofi and Teva Pharmaceuticals present new detailed data from the RELIEVE UCCD study on duvakitug's efficacy in ulcerative colitis and Crohn's disease at ECCO 2025, demonstrating potential for phase 3 program in H2 2025 Ulcerative Colitis Sanofi Teva Pharmaceuticals Crohn's Disease RELIEVE UCCD Study
BRIEF published on 02/19/2025 at 07:35, 11 months 17 days ago Sanofi and CD&R Finalize Opella Share Purchase Agreement Share Purchase Regulatory Approvals Sanofi CD&R Opella
PRESS RELEASE published on 02/19/2025 at 07:30, 11 months 17 days ago Press Release: Sanofi and CD&R sign Opella share purchase agreement Sanofi and CD&R sign share purchase agreement for Opella, with Bpifrance as minority shareholder. Transaction expected to close in Q2 2025, subject to regulatory approvals Share Purchase Agreement Sanofi Bpifrance CD&R Opella
BRIEF published on 02/13/2025 at 20:13, 11 months 23 days ago Sanofi Files 2024 Financial Reports with SEC and AMF Financial Report 2024 SEC Filing Sanofi AMF Compliance
PRESS RELEASE published on 02/13/2025 at 20:08, 11 months 23 days ago Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Sanofi files 2024 U.S. Form 20-F and French Annual Financial Report. Documents available online. Company focused on healthcare innovation Innovation Financial Report Healthcare Form 20-F Sanofi
PRESS RELEASE published on 02/10/2025 at 19:00, 11 months 26 days ago Sanofi: Disclosure of trading in own shares
BRIEF published on 02/07/2025 at 07:05, 1 year ago Sanofi enters into a €2 billion share buyback mandate Share Buyback Investment 2025 Sanofi L'Oréal
PRESS RELEASE published on 02/07/2025 at 07:00, 1 year ago Press Release: Execution of a share buyback agreement for up to €2 billion Sanofi enters €2 billion share buyback agreement for 2025 with investment service provider to repurchase own shares, continuing focus on improvement and innovation in global healthcare sector Share Buyback Sanofi Global Healthcare Investment Service Provider €2 Billion
Published on 02/08/2026 at 21:00, 4 hours 9 minutes ago Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Published on 02/07/2026 at 01:00, 2 days ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 2 days 1 hour ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 2 days 3 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 9 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/07/2026 at 21:00, 1 day 4 hours ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 8 hours ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 8 hours ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 2 days 5 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 days 7 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 2 days 6 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 9 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 18:06, 3 days 7 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026